StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $28.06MP/E –Yield –

Scynexis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Scynexis's operating income for the twelve months ending Jun 30, 2026 was -$22.60M. For fiscal 2025 it was -$16.07M. The highest annual figure on record is $72.67M in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$16.07M–
FY2024Dec 31, 2024-$37.12M-151.1%
FY2023Dec 31, 2023$72.67M–
FY2022Dec 31, 2022-$85.76M–
FY2021Dec 31, 2021-$60.84M–
FY2020Dec 31, 2020-$51.15M–
FY2019Dec 31, 2019-$48.92M–
FY2018Dec 31, 2018-$29.98M–
FY2017Dec 31, 2017-$26.32M–
FY2016Dec 31, 2016-$27.82M–
FY2015Dec 31, 2015-$28.35M–
FY2014Dec 31, 2014-$14.65M–
FY2013Dec 31, 2013-$7.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.78M–
Q1 FY2026Mar 31, 2026-$16.94M–
Q4 FY2025Dec 31, 2025$10.52M–
Q3 FY2025Sep 30, 2025-$8.41M–
Q2 FY2025Jun 30, 2025-$9.56M–
Q1 FY2025Mar 31, 2025-$8.61M–
Q4 FY2024Dec 31, 2024-$8.05M–
Q3 FY2024Sep 30, 2024-$10.32M–
Q2 FY2024Jun 30, 2024-$9.24M-107.9%
Q1 FY2024Mar 31, 2024-$9.51M–
Q4 FY2023Dec 31, 2023-$23.07M–
Q3 FY2023Sep 30, 2023-$10.10M–
Q2 FY2023Jun 30, 2023$116.51M–
Q1 FY2023Mar 31, 2023-$10.68M–
Q4 FY2022Dec 31, 2022-$22.48M–
Q3 FY2022Sep 30, 2022-$21.80M–
Q2 FY2022Jun 30, 2022-$21.74M–
Q1 FY2022Mar 31, 2022-$19.74M–
Q4 FY2021Dec 31, 2021-$22.30M–
Q3 FY2021Sep 30, 2021-$19.44M–
Q2 FY2021Jun 30, 2021-$17.51M–
Q1 FY2021Mar 31, 2021-$1.59M–
Q4 FY2020Dec 31, 2020-$15.34M–
Q3 FY2020Sep 30, 2020-$11.51M–
Q2 FY2020Jun 30, 2020-$11.83M–
Q1 FY2020Mar 31, 2020-$12.48M–
Q4 FY2019Dec 31, 2019-$14.11M–
Q3 FY2019Sep 30, 2019-$11.76M–
Q2 FY2019Jun 30, 2019-$11.20M–
Q1 FY2019Mar 31, 2019-$11.86M–
Q4 FY2018Dec 31, 2018-$8.79M–
Q3 FY2018Sep 30, 2018-$6.30M–
Q2 FY2018Jun 30, 2018-$7.66M–
Q1 FY2018Mar 31, 2018-$7.23M–
Q4 FY2017Dec 31, 2017-$7.16M–
Q3 FY2017Sep 30, 2017-$6.40M–
Q2 FY2017Jun 30, 2017-$6.75M–
Q1 FY2017Mar 31, 2017-$6.02M–
Q4 FY2016Dec 31, 2016-$5.63M–
Q3 FY2016Sep 30, 2016-$6.71M–

More Scynexis figures

See a number that looks wrong?